The Europe Ophthalmic Knives Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).
According to the World Health Organization (WHO), 80% of vision impairment is either avoidable or treatable. This includes refractive defects that have not been addressed, some forms of infancy blindness, cataracts, the illnesses of river blindness and trachoma, diabetic retinopathy, glaucoma, and other eye diseases. The use of assistive technologies, environment modifications, and vision rehabilitation programs benefits a large number of persons with severe visual impairment.
Over 50-year-olds in developing countries make up the bulk of those with poor vision. There are significant financial expenses associated with visual impairments, both primarily from the treatment costs and secondarily through a reduction in productivity. Diabetes, macular degeneration, severe injuries, infections of the cornea or retina, glaucoma, and the inability to use eyeglasses are some of the common conditions that lead to blindness.
The number of persons who are avoidably blind is anticipated to climb as the world's senior population grows, mostly because of age-related vision impairment. These elements are anticipated to increase the frequency of ophthalmic operations, which is anticipated to increase the usage of ophthalmic knives and support the ophthalmic knives market's expansion.
The market is expanding as retinal problems are becoming more common. Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. In the continent of Europe, there are reportedly around 30 million blind and partially sighted people. One in thirty Europeans loses their vision on average, and people who are partially seeing outnumber people who are blind by a factor of four. Compared to men, women are more likely to become blind or partially sighted.
The Germany market dominated the Europe Ophthalmic Knives Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $25,692.2 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.4% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 5% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Eye Clinics and Others. Based on Design, the market is segmented into Slit Knives, MVR Knives, Straight Knives, Crescent Knives and Others. Based on Application, the market is segmented into Cataract Surgery, Glaucoma Surgery and Others. Based on Product, the market is segmented into Reusable Ophthalmic Knives and Disposable Ophthalmic Knives. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Ophthalmic Knives Market is Predict to reach $382.6 Million by 2028, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Core Surgical Limited, Omni Lens Pvt. Ltd., SafeOps Surgical Care Ltd., Neu Micromed International Pvt. Ltd., Mani, Inc., Bausch Health Companies, Inc., Diamatrix Ltd., HAI Laboratories, Inc., Sidapharm P.C. and Bohaikangyuan Medical Co., Ltd.
By End User
By Design
By Application
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
